DUBLIN--(BUSINESS WIRE)--The "Global Critical Care Diagnostics Market - Segmented by Test Type, End User, and Geography - Growth, Trends, and Forecast (2018 - 2023)" report has been added to ResearchAndMarkets.com's offering.
The global critical care diagnostics market is expected to register a CAGR of about 6% during the forecast period of 2018-2023.
Critical care diagnostics is primarily driven by the increased number of physicians and patients demanding early disease diagnosis. As per the study scope of geographical regions, the well-established healthcare infrastructure with the high adoption rate of new technologies and increasing research and development activities provides North America an edge to sustain its high share over other regions to dominate the market.
Factors driving this market are the rising awareness among people for early diagnosis and treatment, rise in the use of data management and connectivity through interoperability to electronic health record (EHR), and rising adoption of telehealth services and remote communications.
- Increasing Prevalence of Chronic Diseases and Lifestyle-related Disorders
- High Cost of Molecular Diagnostics Tools
- United States to Dominate the Market
Key Developments in the Market
- April 2018 - Beckman Coulter Diagnostics announced commercialization of its access sensitive estradiol in the United States for detecting estradiol levels in women, children, and men.
- January 2018 - GE Healthcare entered into the strategic, long-term partnership with Roche to jointly develop digital clinical decision support solutions for cancer and critical care patients.
- Bayer AG
- Dickinson & Company
- Biomrieux SA
- Bio-Rad Laboratories Inc.
- Chembio Diagnostic Systems Inc.
- F. Hoffmann-La Roche
- Siemens Healthineers
- Sysmex Corporation
Key Topics Covered
2. Research Methodology
3. Executive Summary
4. Key Inferences
5. Market Overview
6. Market Dynamics
7. Market Segmentation
8. Competitive Landscape
9. Key Players
10. Future of the Market
For more information about this report visit https://www.researchandmarkets.com/research/j7xf56/global_critical?w=4